Skip to content

Author

Wen-Li Li

We have 3 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

The Effect of Stevioside on Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Stevioside is a widely used natural non-nutritive sweetener derived from Stevia rebaudiana; however, its effects on MASLD and the underlying molecular mechanisms remain unclear. This study aimed to elucidate the effects and mechanisms of stevioside on MASLD, based on the high-fat diet-induced mice model and palmitic ac...

Chang-Fa Zhang, Wen-Li Li, Kang-Jun Li et al. · 0 citations
Open access Sep 2026

Sex differences in risk of cardiovascular disease in participants with cardiovascular-kidney-metabolic syndrome stages 0–3: parallel analyses of two prospective cohorts

The preclinical stages of Cardiovascular-Kidney-Metabolic (CKM) syndrome serve as an important surveillance window for cardiovascular disease (CVD) risk assessment and prevention. However, whether sex-specific differences in CVD risk exist across the CKM syndrome stages 0–3, and whether these differences would va...

Xin-Ru Peng, Wen-Li Li, Yu-Jiong Chen et al. · 0 citations
Open access Jul 2026

Frailty may confound the association between MASLD and cardiovascular mortality in people with cardiometabolic risk factors.

BACKGROUND While metabolic dysfunction-associated steatotic liver disease (MASLD) has been consistently associated with increased cardiovascular risk in the general population, its association with cardiovascular disease (CVD) mortality in adults with established cardiometabolic risk factor (including obesity, hyperten...

Ruoting Wang, Wenli Li, J. Lazarus et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.